HER096: Research, Dosing, and Where to Buy in 2026
A research-first profile for HER096 (HER 096), aggregating mechanism notes, transcript dosing mentions, vendor recommendations, and PubMed-indexed literature without presenting medical guidance.
We were unable to verify the underlying compound, mechanism, or peer-reviewed evidence for HER096. It may be a branded blend, a research-stage compound with thin literature, or a name without a single canonical formulation. Do not assume safety based on this page existing. Independently verify what the product actually contains, talk to a qualified clinician, and check current regulatory status before any consumption decision. We list it educationally so that curiosity doesn't lead someone to unverified sources.
HER096 is a research compound profiled here from named-expert transcripts and peer-reviewed literature, without medical guidance. As of July 2026, The Peptide Wiki aggregates 1 transcript dosing protocol for HER096, each linked to its source.
- Also indexed as HER 096.
- 1 aggregated dosing-protocol mention from source transcripts.
- 0 PubMed-indexed citations listed in the research table below.
- 0 vendor recommendations captured from named experts.
What is HER096?
Research compound aggregated from creator and literature mentions. No direct disease-treatment claims are made on this page.
HER096 Dosing Protocols
The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.
| Speaker | Source | Timestamp | Protocol | Evidence |
|---|---|---|---|---|
| LucasOwen | The DOPAMINE Boosting PEPTIDE You’ve Never Heard Of… | 00:07:11 | Animal study only (not for human use): subcutaneous injection 3x per week in aged mouse Parkinson's model. Human Phase 1A safety data shows CNS penetration after peripheral injection but no human dosing protocol has been established. | anecdotal |
Where to Buy HER096 in 2026
No tracked vendor recommendations for HER096 yet. See our vendor directory.
Side Effects and Safety
Anecdotal reports and study-level observations vary by route, dose, and individual. This page does not provide medical advice. Consult a qualified clinician before any research use.
User Reviews
User reviews aggregator coming Q3 2026 (Reddit + YouTube comments + Discord research notes). Until then, see the expert quote section above and PubMed citations below.
Research Efficacy Snapshot
Published efficacy percentages cited in PubMed trials and named-expert reports about HER096. Each line links to the original source.
- "In cell culture experiments, where researchers were essentially stressing out dopamine neurons to the point of death, HER096 increased dopamine neuron survival by more than 60%." · LucasOwen on "The DOPAMINE Boosting PEPTIDE You’ve Never Heard Of…" @ 6:29
- "Research demonstrated that dopamine neuron survival increased by 46%, alpha-synuclein aggregation was significantly reduced, and neuroinflammation measured by microglial activation was reduced by 84%." · LucasOwen on "The DOPAMINE Boosting PEPTIDE You’ve Never Heard Of…" @ 7:05
Legal Status
HER096 is presented here as a research compound. FDA approval status, scheduling, WADA status, and state-specific telehealth rules may apply. Always verify current regulatory status. Last verified: 2026-07-09.
Frequently Asked Questions
Is HER096 FDA-approved?
HER096 is presented on this page as a research compound. FDA approval status, scheduling, and state-specific rules may apply and change. Verify current regulatory status before any decision.
What dosing is reported for HER096?
This page aggregates 1 dosing-protocol mention(s) from named-expert transcripts, each linked to a verbatim source timestamp. See the Dosing Protocols table above. Mentions are anecdotal, not medical advice.